Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024)
Regentis Biomaterials' (RGNT) quarterly Preferred Stock Liabilities came in at $35.1 million in Q4 2024.
Regentis Biomaterials (RGNT) Preferred Stock Liabilities (2024) Analysis & Trends
Regentis Biomaterials (RGNT) has 1 years of Preferred Stock Liabilities data on file, last reported at $35.1 million in Q4 2024.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $35.1 million in Q4 2024; TTM through Dec 2024 was $35.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $35.1 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q4 2024 stood at $35.1 million.
- Over the last five years, Preferred Stock Liabilities for RGNT reached as high as $35.1 million in Q4 2024 and fell as low as $35.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Regentis Biomaterials | 1.10 Mn | -6.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 35.10 Mn |